Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. Kurse
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit |
|---|---|---|---|---|---|
| Nasdaq | |||||
| Nasdaq Basic | |||||
| Cboe BZX |
Wertentwicklung (Nasdaq)
2,88 %
Intraday
53,58 %
1 Woche
47,25 %
1 Monat
56,27 %
Seit Jahresbeginn
-30,79 %
1 Jahr
-93,82 %
3 Jahre
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,42-12,55
- Jahrestief / Hoch ($)2,90-12,55
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Beschreibung
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
